Name

Asiatic Laboratories

Legal name

Asiatic Laboratories Limited

Website

https://asiaticlaboratories.com

Company type

Public

Founded year

2003

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Asiatic Laboratories Limited is a Bangladeshi pharmaceutical manufacturer and distributor of generic medications, operating an ISO 9001:2008-certified plant in Tongi, Gazipur, and serving the domestic healthcare market through 17 sales and distribution centers and a portfolio of 40+ products across multiple therapeutic categories.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industries

Dermatology Specialty Pharmaceuticals (HLAIACAL), Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF), Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Generic pharmaceutical manufacturing
• Antibiotic formulations
• Cardiovascular medications
• Prescription drug distribution
• Bangladesh pharma industry

Headquarters

HQ city

Dhaka

HQ country

Bangladesh

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Products: Manufacturing and distribution of generic pharmaceutical products across multiple therapeutic categories including antibiotics, antihistamines, cardiac care, vitamins, dermatological products, NSAIDs, antipsychotics, antiulcerants, and eye care.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Asiatic Laboratories Limited manufactures and distributes a diversified portfolio of generic pharmaceutical products across multiple therapeutic categories, including antibiotics, antihistamines, respiratory care, cardiac care, vitamins and minerals, dermatological products, NSAIDs, antipsychotics, antiulcerants, antiemetics, and eye care. The company operates its own ISO 9001:2008 certified manufacturing plant in Tongi, Gazipur, Bangladesh, and reaches customers through a proprietary distribution network of 17 regional Sales & Distribution centers nationwide supported by owned covered vans and rented vehicles.

Product overview

Asiatic Laboratories Limited is a pharmaceutical company based in Bangladesh with a diversified portfolio of generic medications across multiple therapeutic categories. The company manufactures and distributes pharmaceutical products through its own distribution network spanning 15 sales centers throughout Bangladesh. The product portfolio includes flagship brands such as Antison, Afixime, Asizith, Ceroxime, Asixone, Xofena, Eso-20, Calfor D, Ulsec, Lexnil, Ocuvit, Floximox, Tobicort, Refresh TR, and Asilee TS, covering therapeutic areas including antibiotics, antihistamines, respiratory care, cardiac care, eye care, vitamins and minerals, antiulcerants, dermatological products, NSAIDs, and antipsychotics. The company operates a manufacturing plant in Tongi, Gazipur, and distributes its products through its own logistics infrastructure including covered vans.

Differentiator

Problem solved

Functional benefit

Products and services

• Antison Antipsychotic medication for psychiatric conditions; part of Asiatic's flagship brand portfolio.
• Afixime Cephalosporin-class antibiotic for treating bacterial infections; flagship brand.
• Asizith Macrolide-class antibiotic medication; flagship brand.
• Ceroxime Cephalosporin-class antibiotic; flagship brand in Asiatic's antibiotic portfolio.
• Asixone Pharmaceutical product in Asiatic's flagship brand portfolio.
• Xofena Respiratory care medication; flagship brand.
• Eso-20 Antiulcerant medication (esomeprazole) for gastric conditions; flagship brand.
• Calfor D Calcium, vitamin, and mineral supplement; flagship brand.
• Ulsec Antiulcerant medication; flagship brand.
• Lexnil Antipsychotic and tranquilizer medication; flagship brand.
• Ocuvit Ophthalmic eye care product; flagship brand.
• Floximox Eye care antibiotic ophthalmic solution; flagship brand.
• Tobicort Respiratory corticosteroid inhaler; flagship brand.
• Refresh TR Lubricant eye drop product for dry eye relief; flagship brand.
• Asilee TS Respiratory expectorant formulation; flagship brand.
• Ceftiten 400mg Capsule Cephalosporin antibiotic in 400mg capsule form.
• Ceftiten 60ml PFS Pediatric oral suspension antibiotic (60 ml PFS) for children.
• Asitrol Antihistamine for respiratory care.
• Coflyt Cough and cold medication.
• Liam Respiratory care product.
• Xibast Antihistamine for respiratory conditions.
• Ceroxime-CV Combination antibiotic with clavulanic acid.
• Clox-f Penicillin-class antibiotic.
• Dermicon Topical antifungal medication.
• NTZ Anti-infective medication.
• Vecef Cephalosporin antibiotic injection.
• Confree-Nasal Nasal decongestant spray.
• Confree-Paed Pediatric nasal decongestant.
• Optadine-DS Ophthalmic anti-inflammatory eye drop.
• Refresh-i Lubricant eye drops.
• Animet Vitamin and mineral supplement.
• Asibion B-vitamin complex supplement.
• Asitrum Gold Premium multivitamin and mineral supplement.
• Asitrum Silver Standard multivitamin and mineral supplement.
• Asivit ZI Zinc and vitamin supplement.
• Atidon Antiemetic medication for nausea and vomiting.
• O-20 Omeprazole 20mg capsule for acid reflux.
• O-40 Omeprazole 40mg capsule for severe acid conditions.
• Pevisia Topical corticosteroid for skin conditions.
• Protasol Dermatological product for skin conditions.
• Artorix NSAID for pain and inflammation.
• Locopain-TR Extended-release analgesic for chronic pain.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves6 records

Expansion highlights3 records

Direct peers

• ACI Limited (Pharma division): Bangladeshi conglomerate whose pharma division manufactures generics across antibiotics, cardiac, and other categories. Overlaps with Asiatic on generic pharma products and Bangladesh-only distribution, with additional FMCG/consumer health scale.
• Incepta Pharmaceuticals: Bangladeshi generic pharma manufacturer with a very broad therapeutic portfolio and a strong export business. Competes with Asiatic in the same retail/generic channels in Bangladesh and operates a comparable manufacturing-and-distribution model.
• Renata Limited: Public Bangladeshi pharma company with a large generics portfolio and meaningful animal health and biologics exposure. Direct comparable to Asiatic on generic pharma mix, public listing on DSE, and Bangladesh-centric distribution.
• Square Pharmaceuticals: Bangladesh's largest pharmaceutical manufacturer, producing generics across virtually every therapeutic category and exporting to over 40 countries. Directly comparable to Asiatic in therapeutic breadth, generic-pharma focus, and Bangladesh-only manufacturing footprint, but at materially larger scale.
• Healthcare Pharmaceuticals: Bangladeshi pharmaceutical company with a generic-focused portfolio spanning multiple therapeutic categories. Closely comparable to Asiatic in size, therapeutic mix, and Bangladesh-only footprint.
• General Pharmaceuticals Ltd: Bangladeshi generics manufacturer with ISO-certified facilities and a multi-therapeutic portfolio. Closely comparable to Asiatic in scale, product mix, and Bangladesh-only distribution.
• Drug International Limited: Bangladeshi generic pharma manufacturer with products in antibiotics, cardiac, antiulcerants, and other categories. Direct competitor in the same domestic generic market with a similar product-portfolio strategy.
• Eskayef Pharmaceuticals (Transcom): Bangladeshi pharma manufacturer with a broad generics portfolio and growing exports. Comparable to Asiatic on therapeutic breadth, generic positioning, and Bangladesh manufacturing base.
• Beximco Pharmaceuticals: Listed Bangladeshi generic pharma manufacturer with a diversified therapeutic portfolio and one of the first Bangladeshi pharma companies to gain US FDA approval. Most comparable to Asiatic on product mix, distribution model, and public-company status.

Broad incumbents

• GlaxoSmithKline Bangladesh: Multinational pharma with a Bangladesh operation selling branded prescription products. Operates in the same therapeutic categories and channels as Asiatic but with a multinational parent, global supply chain, and broader portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/AsiaticLaboratories
• LinkedInlinkedin.com/company/asiatic-laboratories-ltd.

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Asiatic Laboratories